Old Web
English
Sign In
Acemap
>
authorDetail
>
Koji Fujii
Koji Fujii
Janssen Pharmaceutica
Apalutamide
Oncology
Subgroup analysis
Population
Internal medicine
2
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study.
2020
International Journal of Urology
Hirotsugu Uemura
Gaku Arai
Hiroji Uemura
Hiroyoshi Suzuki
Kazuyoshi Iijima
Kazuo Nishimura
Koji Fujii
Tomoyoshi Hatayama
Junya Aoyama
Kris Deprince
Angela Lopez-Gitlitz
Sharon Anne McCarthy
Julie S. Larsen
Jinhui Li
Kim N. Chi
Show All
Source
Cite
Save
Citations (3)
Efficacy and safety of apalutamide in Japanese patients with non-metastatic castration-resistant prostate cancer: A subgroup analysis of a randomized, double-blind, placebo-controlled, phase 3 study
2020
Prostate international
Hiroji Uemura
Takefumi Satoh
Hideyasu Tsumura
Gaku Arai
Keiichiro Imanaka
Kazuhiro Shibayama
Koji Fujii
Brendan Rooney
Angela Lopez-Gitlitz
Byron M. Espina
Carlos Perez Ruixo
Eric J. Small
Matthew R. Smith
Show All
Source
Cite
Save
Citations (4)
1